Document:

Exhibit 10.62

 

EXHIBIT 10.62

IDM Pharma, Inc.

2000 Stock Plan

Restricted Stock Bonus Agreement

     Pursuant to the Restricted Stock Bonus Grant Notice (“Grant Notice”) and this Restricted
Stock Bonus Agreement (collectively, the “Award”) and in consideration of your past services, IDM
Pharma, Inc. (the “Company”) has awarded you a stock bonus under its 2000 Stock Plan (the “Plan”)
for the number of shares of the Company’s Common Stock subject to the Award as indicated in the
Grant Notice. Defined terms not explicitly defined in this Restricted Stock Bonus Agreement but
defined in the Plan shall have the same definitions as in the Plan.

     The details of your Award are as follows:

     1. Vesting. Subject to the limitations contained herein, your Award will vest as
provided in the Grant Notice, provided that vesting will cease upon the termination of your
Continuous Service.

     2. Number of Shares. The number of shares subject to your Award may be adjusted from
time to time for capitalization adjustments, as provided in the Section 12(a) of the Plan.

     3. Securities Law Compliance. You may not be issued any shares under your Award
unless the shares are either (i) then registered under the Securities Act or (ii) the Company has
determined that such issuance would be exempt from the registration requirements of the Securities
Act. Your Award must also comply with other applicable laws and regulations governing the Award,
and you will not receive such shares if the Company determines that such receipt would not be in
material compliance with such laws and regulations.

     4. Limitations on Transfer. In addition to any other limitation on transfer created
by applicable securities laws, you shall not sell, assign, hypothecate, donate, encumber or
otherwise dispose of any interest in the Common Stock while the Common Stock is subject to the
Reacquisition Right described in Section 5 below. After any Common Stock has been released from
the Reacquisition Right, you shall not sell, assign, hypothecate, donate, encumber or otherwise
dispose of any interest in the Common Stock except in compliance with the provisions herein and
applicable securities laws.

     5. Right of Reacquisition. To the extent provided in the Company’s bylaws, as
amended from time to time, the Company shall have the right to reacquire all or any part of the
shares received pursuant to your Award (a “Reacquisition Right”).

     6. Effect of Certain Corporate Transactions. In the event of a corporate transaction
as described in Section 12 of the Plan where an acquiring or surviving corporation assumes,
continues or substitutes your Award, the Reacquisition Right may be assigned by the Company to the
successor of the Company (or such successor’s parent company), if any, in connection with such
corporate transaction. To the extent the Reacquisition Right remains in

 

 

effect following such corporate transaction, it shall apply to the new capital stock or other
property received in exchange for the Common Stock in consummation of the corporate transaction,
but only to the extent the Common Stock was at the time covered by such right.

     7. Restrictive Legends. The shares issued under your Award shall be endorsed with
appropriate legends determined by the Company.

     8. Award not a Service Contract. Your Award is not an employment or service
contract, and nothing in your Award shall be deemed to create in any way whatsoever any obligation
on your part to continue in the employ of the Company or an Affiliate, or on the part of the
Company or an Affiliate to continue your employment. In addition, nothing in your Award shall
obligate the Company or an Affiliate, their respective stockholders, boards of directors, Officers
or Employees to continue any relationship that you might have as a Director or Consultant for the
Company or an Affiliate.

     9. Withholding Obligations.

          (a) At the time your Award is made, or at any time thereafter as requested by the Company, you
hereby authorize withholding from payroll and any other amounts payable to you, and otherwise agree
to make adequate provision for any sums required to satisfy the federal, state, local and foreign
tax withholding obligations of the Company or an Affiliate, if any, which arise in connection with
your Award.

          (b) Unless the tax withholding obligations of the Company and/or any Affiliate are satisfied,
the Company shall have no obligation to issue a certificate for such shares or release such shares
from any escrow provided for herein.

     10. Notices. Any notices provided for in your Award or the Plan shall be given in
writing and shall be deemed effectively given upon receipt or, in the case of notices delivered by
the Company to you, five (5) days after deposit in the United States mail, postage prepaid,
addressed to you at the last address you provided to the Company.

     11. Miscellaneous.

          (a) The rights and obligations of the Company under your Award shall be transferable to any
one or more persons or entities, and all covenants and agreements hereunder shall inure to the
benefit of, and be enforceable by the Company’s successors and assigns. Your rights and obligations
under your Award may only be assigned with the prior written consent of the Company.

          (b) You agree upon request to execute any further documents or instruments necessary or
desirable in the sole determination of the Company to carry out the purposes or intent of your
Award.

          (c) You acknowledge and agree that you have reviewed your Award in its entirety, have had an
opportunity to obtain the advice of counsel prior to executing and accepting your Award and fully
understand all provisions of your Award.

 

 

     12. Governing Plan Document. Your Award is subject to all the provisions of the
Plan, the provisions of which are hereby made a part of your Award, and is further subject to all
interpretations, amendments, rules and regulations which may from time to time be promulgated and
adopted pursuant to the Plan. In the event of any conflict between the provisions of your Award
and those of the Plan, the provisions of the Plan shall control.

 

 

IDM Pharma, Inc.

Restricted Stock Bonus Grant Notice

(2000 Stock Plan)

IDM Pharma, Inc. (the “Company”), pursuant to its 2000 Stock Plan (the “Plan”), hereby awards
to Participant as a bonus the number of shares of the Company’s Common Stock set forth below
(“Award”). This Award is subject to all of the terms and conditions as set forth herein and in the
Restricted Stock Bonus Agreement and the Plan, each of which is attached hereto and incorporated
herein in their entirety.

	 	 	 
	Participant:

	 	Emile Loria, M.D.
	Date of Grant:

	 	December 30, 2005
	Vesting Commencement Date:

	 	December 30, 2005
	Number of Shares Subject to Award:

	 	50,000
	Consideration:

	 	Participant’s Past Services

			
	Vesting Schedule:	 	100%  of the shares will vest immediately.

Additional Terms/Acknowledgements: The undersigned Participant acknowledges receipt of, and
understands and agrees to, this Restricted Stock Bonus Grant Notice, the Restricted Stock Bonus
Agreement and the Plan. Participant further acknowledges that as of the Date of Grant, this
Restricted Stock Bonus Grant Notice, the Restricted Stock Bonus Agreement and the Plan set forth
the entire understanding between Participant and the Company regarding the acquisition of stock in
the Company and supersede all prior oral and written agreements on that subject with the exception
of (i) Awards previously granted and delivered to Participant under the Plan, and (ii) the
following agreements only:

	 	 	 	 	 
	 

	 	Other Agreements:
	None	
	 

	 	 	 
	 
	 	 	 	 
	 

	 	 	 

	 	 	 	 	 	 	 
	IDM Pharma, Inc.	 	Participant:
	 
	 	 	 	 	 	 
	By:	 	/s/ Robert De Vaere	 	/s/ Emile Loria
	 	 	 	 	 
	 

	 	Signature
	 	 	 	Signature
	 
	 	 	 	 	 	 
	Title:

	 	CFO
	 	Date:
	 	January 4, 2006
	 

	 	 
	 	 	 	 
	 
	 	 	 	 	 	 
	Date:

	 	January 4, 2006	 	 	 	 
	 

	 	 	 	 	 	 

			
	Attachments:	 	Restricted Stock Bonus Agreement 2000 Stock Plan.Exhibit 10.63

 

Exhibit 10.63

IDM PHARMA, INC.

DIRECTORS’ DEFERRED COMPENSATION PLAN

 

Effective as of March 17, 1995

Amended September 20, 1996

Amended and Restated July 13, 1999

Amended and Restated Effective as of January 1, 2005

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 
	 	 	 	 	Page	 
	1.
	 	Purpose of the Plan	 	 	1	 
	2.
	 	Definitions	 	 	1	 
	 
	 	2.1 Account	 	 	1	 
	 
	 	2.2 Beneficiary	 	 	1	 
	 
	 	2.3 Benefit	 	 	1	 
	 
	 	2.4 Board	 	 	1	 
	 
	 	2.5 Code	 	 	2	 
	 
	 	2.6 Company	 	 	2	 
	 
	 	2.7 Compensation	 	 	2	 
	 
	 	2.8 Compensation Reductions	 	 	2	 
	 
	 	2.9 Deferred Compensation Agreement	 	 	2	 
	 
	 	2.10 Director	 	 	2	 
	 
	 	2.11 Effective Date	 	 	2	 
	 
	 	2.12 Eligible Director	 	 	2	 
	 
	 	2.13 Fair Market Value	 	 	2	 
	 
	 	2.14 Non-Employee Director	 	 	2	 
	 
	 	2.15 Participant	 	 	2	 
	 
	 	2.16 Plan	 	 	2	 
	 
	 	2.17 Plan Year	 	 	2	 
	 
	 	2.18 Share.	 	 	3	 
	 
	 	2.19 Valuation Date	 	 	3	 
	3.
	 	Participation	 	 	3	 
	 
	 	3.1 Participation of Eligible Directors	 	 	3	 
	 
	 	3.2 Irrevocability of Participation During the Plan Year.	 	 	4	 
	 
	 	3.3 Suspended Participation.	 	 	4	 
	 
	 	3.4 Termination of Participation	 	 	4	 
	4.
	 	Plan Accounts	 	 	4	 
	 
	 	4.1 Accounts	 	 	4	 
	 
	 	4.2 Investment of Accounts	 	 	4	 
	 
	 	4.3 Value of Accounts.	 	 	5	 

1

 

	 	 	 	 	 	 	 
	 	 	 	 	Page	 
	 
	 	4.4   Funds Unsecured	 	 	5	 
	5.
	 	Benefits	 	 	5	 
	 
	 	5.1   Retirement Benefits	 	 	5	 
	 
	 	5.2   Death Benefits	 	 	6	 
	6.
	 	Source of Benefits	 	 	6	 
	7.
	 	Administration	 	 	6	 
	 
	 	7.1   General	 	 	6	 
	 
	 	7.2   Procedures	 	 	6	 
	 
	 	7.3   Claims	 	 	6	 
	8.
	 	Amendment and Termination	 	 	7	 
	 
	 	8.1   Amendment or Termination	 	 	7	 
	 
	 	8.2   Accrued Benefits	 	 	7	 
	9.
	 	Adjustment of Shares; Sale or Merger of the Company	 	 	7	 
	 
	 	9.1   Adjustment of Shares	 	 	7	 
	 
	 	9.2   Sale or Merger of the Company	 	 	8	 
	10.
	 	Miscellaneous	 	 	8	 
	 
	 	10.1   Benefits Fully Vested	 	 	8	 
	 
	 	10.2   No Right to Continue as Director	 	 	8	 
	 
	 	10.3   Successors and Assigns	 	 	8	 
	 
	 	10.4   Assignment or Alienation	 	 	8	 
	 
	 	10.5   Entire Agreement	 	 	8	 
	 
	 	10.6   Headings	 	 	8	 
	 
	 	10.7   Gender and Number	 	 	9	 
	 
	 	10.8   Governing Law	 	 	9	 

2

 

IDM PHARMA, INC.

DIRECTORS’ DEFERRED COMPENSATION PLAN

(As Amended and Restated Effective January 1, 2005)

     IDM Pharma, Inc., a Delaware corporation (the “Company”), previously adopted
effective as of March 17, 1995 the IDM Pharma, Inc. Directors’ Deferred Compensation Plan (the
“Plan”) as an amendment and restatement of the Cytel Corporation Directors’ Deferred Compensation
Plan for the nonemployee directors of the Company upon the terms and conditions set forth below.

     The Company believes that it is in its best interests to amend and restate this Plan effective
as of January 1, 2005 with respect to Post-2004 Deferrals for purposes of compliance with Section
409A of the Internal Revenue Code of 1986, as amended, and its regulations and other guidance
thereunder.

     The benefits payable under the Plan are and at all times will be mere unsecured contractual
rights against the Company payable from the Company’s general assets. It is intended that the Plan
shall constitute an unfunded deferred compensation arrangement for purposes of United States
federal income tax laws, and all documents, agreements or instruments made or given pursuant to the
Plan shall be interpreted so as to carry out this intent.

1.   Purpose of the Plan

     The purpose of this Plan is to provide deferred compensation benefits to nonemployee directors
of the Company, payable by the Company. This Plan will provide benefits derived from contributions
by the Company hereunder of a nonemployee director’s compensation as to which he or she has elected
to defer payment under the Plan.

2.   Definitions

     The capitalized terms defined in this Section 2 shall have the meanings set forth below:

     2.1   Account.   A separate Plan account, which is a bookkeeping record, established for each
Participant to which shall be allocated Compensation Reductions in accordance with Section 4.1.

     2.2   Beneficiary.   The beneficiary or beneficiaries designated by a Participant to receive any
remaining Benefits due under the Plan after his or her death. If the Participant has not
designated a Beneficiary, the Beneficiary shall be the Participant’s surviving spouse or, if none,
the Participant’s estate.

     2.3   Benefit.   The benefit or benefits provided under this Plan, which for a Participant shall
be equal to the account balance of such Participant’s Account.

     2.4   Board.   The Board of Directors of the Company.

1

 

     2.5   Code.   The Internal Revenue Code of 1986, as it may be amended from time to time.

     2.6   Company.   IDM Pharma, Inc., a Delaware corporation, or any successor corporation.

     2.7   Compensation.   All the non-equity fees (paid in cash or by check) received by a
Participant from the Company for a Plan Year for his or her services as a Director, including but
not limited to, the retainer fee and meeting attendance fees.

     2.8   Compensation Reductions.   The percentage of Compensation which a Participant has elected
to defer pursuant to a Deferred Compensation Agreement, and that the Company and the Participant
mutually agree shall be deferred in accordance with the Plan. Participants may elect to defer any
whole percentage of Compensation up to 100% of Compensation.

     2.9   Deferred Compensation Agreement.   An agreement by which a Participant elects to reduce a
selected whole percentage of his or her Compensation for a Plan Year in order for the Company to
make contributions to the Plan on his or her behalf.

     2.10   Director.   A member of the Board.

     2.11   Effective Date.   March 17, 1995.

     2.12   Eligible Director.   A Director who is not an employee of the Company.

     2.13   Fair Market Value.   The fair market value of a share of Common Stock of the Company is
the closing sales price for such stock as quoted on a national securities exchange or the NASDAQ
National Market System of the National Association of Securities Dealers, Inc. Automated Quotation
System on the day of determination, as reported in The Wall Street Journal or such other source as
the Company deems reliable.

     2.14   Non-Employee Director.   A Director who either (i) is not a current employee or officer of
the Company or its parent or subsidiary, does not receive compensation (directly or indirectly)
from the Company or its parent or subsidiary for services rendered as a consultant or in any
capacity other than as a Director (except for an amount as to which disclosure would not be
required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act of 1933, as
amended (“Regulation
S-K”)), does not possess an interest in any other transaction as to which disclosure would be
required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship as to
which disclosure would be required under Item 404(b) of Regulation S-K; or (ii) is otherwise
considered a “non-employee director” for purposes of Rule 16b-3 promulgated under the Exchange Act
of 1934, as amended.

     2.15   Participant.   Any Eligible Director who has elected to participate in the Plan by
entering into a Deferred Compensation Agreement.

     2.16   Plan.   This IDM Pharma, Inc. Directors’ Deferred Compensation Plan, as amended from time
to time.

2

 

     2.17   Plan Year.   The calendar year.

     2.18   Post-2004 Deferrals.   The portion of the Account other than Pre-2005 Deferrals. The Plan
shall maintain separate accounting for Post-2004 Deferrals.

     2.19   Pre-2005 Deferrals.   That portion of the Account determined as of December 31, 2004, to
which the Participant has a legally binding right to be paid, and the right to which is earned and
vested as of December 31, 2004, in accordance with Section 409A and its regulations and other
guidance thereunder, plus earnings and losses allocable to such amounts. The Plan shall maintain
separate accounting for Pre-2005 Deferrals.

     2.20   Share.   A participating interest under the Plan, which shall be equal to the Fair Market
Value of a share of Common Stock of the Company.

     2.21   Termination of Service.   A Participant’s termination of directorship for any reason that
is a “separation from service” from the Company for purposes of Section 409A of the Code. The
determination of whether a Participant has had a Termination of Service shall be made in a manner
consistent with Section 409A of the Code and the regulations and other guidance thereunder.

     2.22   Valuation Date.   The last day of each calendar quarter, or such other date as shall be
established by the Company.

3.   Participation

     3.1   Participation of Eligible Directors.

          (a)   Each Eligible Director may begin to participate in the Plan on the Effective Date;
provided, however, that such Eligible Director completes and signs a Deferred Compensation
Agreement and returns such Deferred Compensation Agreement to the designated representative of the
Company prior to the Effective Date or such earlier date established by the Company and announced
to the Eligible Director. Such Deferred Compensation Agreement shall be effective for the period
beginning on the Effective Date and ending on December 31, 1995.

          (b)   Each Director who becomes an Eligible Director after the Effective Date may begin to
participate in the Plan by completing and signing a Deferred Compensation Agreement and returning
such Deferred Compensation Agreement to the designated representative of the Company; provided,
however, that such completion and return of the Deferred Compensation Agreement to the Company
occurs within thirty (30) days after the date that the Director becomes an Eligible Director. Such
Deferred Compensation Agreement shall be effective with respect to the portion of Compensation
attributable to services performed by the Director during the period beginning on the date the
Eligible Director completes and returns the Deferred Compensation Agreement to the Company and
ending on the last day of the Plan Year within which such participation begins, which will
generally include the retainer fees and meeting attendance fees that would otherwise have been paid
to the Eligible Director during the remainder of the Plan Year following the return of the Deferred
Compensation Agreement. Once the Eligible Director completes and returns the Deferred Compensation
Agreement to the

3

 

Company within the thirty (30) day period after the date that the Director becomes
an Eligible Director, the election is irrevocable. Notwithstanding the foregoing, any Deferred
Compensation Agreement completed and returned to the Company on or after December 19, 2005 shall
continue to be effective for subsequent Plan Years unless and until the Participant completes and
returns a new Deferred Compensation Agreement in accordance with Section 3.1(d) below.

          (c)   An Eligible Director who did not become a Participant in accordance with the terms of
paragraph (a) or (b) may participate in the Plan effective as of the beginning of any Plan Year
following the Plan Year in which he or she becomes an Eligible Director by completing and signing a
Deferred Compensation Agreement and returning such Deferred Compensation Agreement to the
designated representative of the Company prior to the beginning of the Plan Year (or such earlier
date established by the Company and announced to the Eligible Director) for which deferral of
Compensation is intended to commence. For deferral elections made for the 2005 Plan Year and any
previous Plan Years, such Deferred Compensation Agreement shall be effective only for the Plan Year
first following the submission of the Deferred Compensation Agreement. For deferral elections made
for the 2006 Plan Year and any subsequent Plan Years, such Deferred Compensation Agreement shall
continue to be effective for subsequent Plan Years unless and until the Participant completes and
returns a new Deferred Compensation Agreement in accordance with Section 3.1(d) below.

          (d)   If a Participant wishes to commence deferrals of Compensation under the terms of the Plan
or change his or her elected percentage of deferred Compensation for any Plan Year subsequent to
the first Plan Year in which the Participant began to participate in the Plan, such Participant
must complete and sign a new Deferred Compensation Agreement and return such Deferred Compensation
Agreement to the designated representative of the Company prior to the beginning of the Plan Year
(or such earlier date established by the Company and announced to the Participant) for which such
election is to be effective. For deferral elections made for the 2005 Plan Year and any previous
Plan Years, such Deferred Compensation Agreement shall be effective only for that Plan Year. For
deferral elections made for the 2006 Plan Year and any subsequent Plan Years, such Deferred
Compensation Agreement shall continue to be effective for subsequent Plan Years unless and until
the Participant completes and returns a new Deferred Compensation Agreement.

     3.2   Irrevocability of Participation During the Plan Year.   A Participant may not
terminate or modify his or her Deferred Compensation Agreement with respect to a Plan Year on or
after the first day of such Plan Year.

     3.3   Suspended Participation.   If a Participant ceases to be an Eligible Director, but
continues to be a Director, he or she shall not be eligible to make future elections to defer
Compensation under the Plan for subsequent Plan Years. Distributions shall be made to such
Participant as would otherwise be permitted in accordance with the distribution provisions under
this Plan. If such Participant again becomes an Eligible Director in a Plan Year following the
last Plan Year for which a Deferred Compensation Agreement was in effect, such Participant may
elect to participate in the Plan by following the procedures specified in Section 3.1(b).

     3.4   Termination of Participation.   A Participant shall cease to be a Participant as of the
date he or she ceases serving as a Director.

4

 

4.   Plan Accounts

     4.1   Accounts.   The Company shall maintain or cause to be maintained for each Participant an
Account with respect to which the Company shall allocate amounts equal to the Participant’s
Compensation Reductions for each Plan Year, effective as of the date such Compensation Reductions
would have been paid to the Participant as Compensation in the absence of a Deferred Compensation
Agreement.

4.2   Investment of Accounts.

          (a)   Each Compensation Reduction allocated to a Participant’s Account shall be converted into
that number of Shares that equal the amount of such Compensation Reduction divided by the Fair
Market Value of the Common Stock of the Company as of the date such Compensation Reduction would
have been paid to the Participant as Compensation in the absence of a Deferred Compensation
Agreement. The calculation of the number of Shares need not be rounded to the nearest whole Share,
so that a fraction of a Share (calculated to the nearest one-hundredth of a Share) may be allocated
to a Participant’s Account.

          (b)   In the event any dividends or distributions are made with respect to the Common Stock of
the Company, the Company shall allocate an amount to the Participant’s Account that is equal to the
amount of such dividends or distributions that would have been made with respect to the Shares
allocated to a Participant’s Account if they were shares of the Common Stock of the Company. Such
dividend/distribution allocations shall be converted into that number of whole and/or fractional
Shares that equal the amount of such allocation divided by the Fair Market Value of the Common
Stock of the Company as of the date such dividends or distributions are made with respect to the
Common Stock of the Company to the Company’s stockholders of record.

     4.3   Value of Accounts.   The value of a Participant’s Account as of any Valuation Date shall be
equal to the number of Shares
allocated to a Participant’s Account multiplied by the Fair Market Value of one share of the Common
Stock of the Company.

     4.4   Funds Unsecured.   Notwithstanding any other provisions of this Plan, all Benefits payable
under the Plan are subject to the claims of the general creditors of the Company. No trust shall
be established to hold any assets which may be set aside by the Company to pay the Benefits under
the Plan and the Company shall be under no obligation to set aside any amounts to pay Benefits.
The maintenance of separate Accounts by the Company as provided herein shall neither require nor be
considered a segregation of any funds or property from the Company’s general assets. Participants
shall have no preferred claim on or beneficial ownership interest in any assets of the Company
prior to the time actual payments of Benefits are received, and all rights of the Participants to
Benefits are mere unsecured contractual rights against the Company.

5.   Benefits

     5.1   Termination Benefits—Distribution of Deferrals.

5

 

          (a)   For Pre-2005 Deferrals, when a Participant ceases serving as a Director, the Participant
shall be entitled to receive the value of his or her Account determined as of the Valuation Date
coinciding with or next preceding the date of the distribution.

          (b)   For Post-2004 Deferrals, when a Participant has a Termination of Service, the Participant
shall be entitled to receive the value of his or her Account determined as of the Valuation Date
coinciding with or next preceding the date of the distribution.

     5.2   Form of Distribution.

          (a)   If at the time the Participant is entitled to a distribution pursuant to Section 5.1, the
total distributable amount is less than $50,000, the distribution shall be paid out by the Company
in cash (or by check) in a single lump sum payment in accordance with Section 5.3.

          (b)   If at the time the Participant is entitled to a distribution pursuant to Section 5.1, the
total distributable amount is at least $50,000, the distribution shall be paid out by the Company
in cash (or by check) in equal annual installments (by reference to the number of Shares allocated
to a Participant’s Account) as follows. The number of installment payments shall be the lesser of
(i) ten (10) or (ii) two (2) times the number of Plan Years the Participant elected to defer
Compensation under the Plan.

          (c)   Notwithstanding the foregoing, to the extent permitted by Section 409A of the Code and the
regulations and other guidance thereunder, the Administrator may, in it sole discretion, override
or modify the timing of payment of a Participant’s Benefits under this Plan at any time and for any
reason to either accelerate or delay the timing of payment of such Benefits in whole or in part.
Such modifications may apply to some or all one or more Participant
Accounts, as determined in the Administrator’s discretion, even as to future installments
payable to a Participant under a distribution that has already commenced pursuant to Section
5.2(b).

     5.3   Timing of Payments.   If a Participant ceases serving as a Director on or before June 30 of
any Plan Year, the lump sum payment or the first installment payment shall be paid by the Company
no later than the last day of such Plan Year. If the Participant ceases serving as a Director on
or after July 1 of any Plan Year, the lump sum payment or the first installment payment shall be
paid by the Company no later than January 31 of the following Plan Year. If the payment of a
Participant’s Account is made in installment payments, the second installment payment shall be paid
during January of the Plan Year following the Plan Year in which the first installment payment was
paid and all remaining installment payments shall be paid annually in the month of January. The
value of an installment shall be determined by multiplying the number of Shares to be paid out in
such installment by the Fair Market Value of one share of the Company’s Common Stock on the last
trading day immediately preceding such installment payment.

     5.4   Death Benefits.   In the event the Participant dies prior to receiving all of his or her
Benefits, his or her remaining Benefits shall be paid by the Company in cash (or by check) to the
Participant’s Beneficiary in a lump sum payment as soon as administratively feasible after the
Participant’s death.

6

 

     5.5   Acceleration of Payments.   Except as provided in Section 5.2(c), payments under the Plan
may be accelerated only upon the occurrence of an event specified in this Section 5.3.

          (a)   Domestic Relations Order. A payment may be accelerated if such payment is made to an
alternate payee pursuant to and following the receipt and qualification of a domestic relations
order as defined in Section 414(p) of the Code.

          (b)   Divestiture. payment may be accelerated as may be necessary to comply with a certificate
of divestiture as defined in Section 1043(b)(2) of the Code.

          (d)   A payment may be accelerated to the extent required to pay any income tax imposed under
Section 409A of the Code (the “Section 409A Amount”) if at any time the Participant’s deferred
compensation arrangement fails to meet the requirements of Section 409A of the Code and the
regulations and other guidance thereunder. The total payment under this subsection (d) may not
exceed the Section 409A Amount.

          (f)   A payment may be accelerated in the Administrator’s discretion in connection with any of
the following events, in accordance with the requirements of Section 409A of the Code and the
regulations and other guidance thereunder:

          (1)   a corporate dissolution taxed under Section 331 of the Code,

          (2)   with the approval of a bankruptcy court pursuant to 11 U.S.C. Section 503(b)(1)(A);

          (3)   a change in control event for purposes of Section 409A of the Code and its
regulations and other guidance thereunder;

          (4)   the termination of the Plan and all other plans that would be aggregated with the
Plan for purposes of Section 409A of the Code; and

          (5)   such other events and conditions as permitted by Section 409A of the Code and the
regulations and other guidance thereunder.

     5.6   No Discretionary Distributions.   Except as expressly provided herein, the Administrator
shall not exercise discretion with respect to timing or form of distribution of Benefits from the
Plan, but shall make distributions at the time and in the manner specified in the Plan.

     5.7   Special Delay in Distribution Rules.   Notwithstanding anything to the contrary set forth
herein, the Administrator retains the right, in its sole discretion, to delay distributions under
the Plan to the extent permitted by Section 409A of the Code and its regulations and other guidance
thereunder.

6.   Source of Benefits

     Benefits payable under this Plan shall be paid out of the Company’s general assets and
allocated as payments out of the appropriate Participant’s Account under the Plan.

7

 

7.   Administration 

     7.1   General.   This Plan shall be administered by the Board of Directors of the Company, unless
and until the Board delegates administration to a committee composed of not fewer than two members
of the Board. All members of such committee shall be Non-Employee Directors, unless the Board
expressly declares otherwise. The Board or, if applicable, such committee (the “Administrator”)
shall exercise all administrative powers and duties under the Plan in accordance with the terms and
purposes of the Plan. The Administrator shall determine the amount of the Benefits due to each
Participant or Beneficiary from this Plan and shall cause them to be paid accordingly in accordance
with the Plan.

     7.2   Procedures.   The Administrator may adopt such rules and regulations not inconsistent with
the provisions of the Plan as deemed necessary or appropriate for the proper administration of the
Plan and shall have the authority, in the Administrator’s sole discretion, to interpret and
construe any provision of the Plan. To the extent permitted by law, (i) all such rules,
regulations, interpretations and constructions shall be final and binding on the Company and all
Participants and their legal representatives, beneficiaries, successors, and assigns, subject to
review as provided in Section 7.3, (ii) the Administrator shall not be subject to any individual
liability with respect to the Plan and (iii) the Administrator shall be indemnified by the Company
for any action or omission made with respect to the Plan which does not demonstrate bad faith,
willful misconduct, criminal act, or gross negligence.

     7.3   Claims.   Any denial by the Administrator of a claim for benefits under the Plan by a
Participant or Beneficiary shall be stated in writing by the Administrator and delivered or mailed
to the Participant or Beneficiary. Such notice shall set
forth the specific reasons for the denial, written to the best of the Administrator’s ability in a
manner that may be understood without legal counsel. In addition, the Administrator shall afford a
reasonable opportunity to any Participant or Beneficiary whose claim for benefits has been denied
for a review of the decision denying the claim. In the event of further disagreement following any
further decision of the Administrator after such a review, either the Participant or the
Administrator may appeal to the full Board, which decision shall be final.

8.   Amendment and Termination

     8.1   Amendment or Termination.   While the Company intends and expects the Plan to continue to
fulfill its purposes and serve the best interests of the Company in its present form, the Company
reserves the right to amend or terminate the Plan at any time and for any reason, subject to the
provisions of Section 8.2 and Section 9.

     8.2   Accrued Benefits.

          (a)   No termination of the Plan or any amendments thereto which affect Benefits under the Plan
shall, without the written consent of a Participant, eliminate or reduce any Benefit of the
Participant under the Plan to which, as of the date of such termination or amendment, such
Participant would be entitled under the provisions of Section 5 had he or she ceased serving as a
Director immediately prior to such date.

8

 

          (b)   In the event of any amendment of the Plan which affects the amount of Benefits payable
under the Plan, Participants shall be entitled to receive the greater of (i) the Benefit provided
under the Plan as amended, or (ii) the Benefit described above in Section 8.2(a).

          (c)   For Pre-2005 Deferrals, upon termination of the Plan, all Deferred Compensation Agreements
shall terminate immediately and all Participants’ full Compensation on a non-deferred basis will be
restored. Each and every Participant shall receive payment of the value of his or her Account in
accordance with the provisions of Section 5 as if such Participant had ceased serving as a Director
on the date of the Plan’s termination.

          (d)   For Post-2004 Deferrals, upon termination of the Plan, all Deferred Compensation
Agreements shall terminate immediately and all Participants’ full Compensation on a non-deferred
basis will be restored. Each and every Participant shall receive payment of the value of his or
her Account in accordance with the provisions of Section 5 in connection with his or her actual
Termination of Service.

9.   Adjustment of Shares; Sale or Merger of the Company

     9.1   Adjustment of Shares.   If any change is made in the Common Stock of the Company pursuant
to which the value of a Share is determined, without the receipt of consideration by the Company
(through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend,
dividend in property other than cash, stock split, liquidating dividend, combination of shares,
exchange of shares, change in corporate structure or other transaction not involving the receipt of
consideration by the Company), the number of Shares held in a Participant’s Account will be
appropriately adjusted. The Board shall make such adjustments, and its determination shall be
final, binding and conclusive. For this purpose, the conversion of any convertible securities of
the Company shall not be treated as a transaction “without receipt of consideration” by the
Company.

     9.2   Sale or Merger of the Company.   In the event of a sale, merger, reorganization,
consolidation or other similar transaction (a “Change of Ownership Transaction”) involving the
Company, no Participant in the Plan will be considered to have ceased serving as a Director for
purposes of the Plan, nor will any such Participant be entitled to receive Benefits pursuant to
Section 5, until such Participant actually ceases serving as Director of the Company or any
acquiring or successor company or entity. Notwithstanding the foregoing, to the extent permitted
by Section 409A of the Code and the regulations and other guidance thereunder, in connection with a
Change of Ownership Transaction, immediate payment of Benefits may be directed by the Administrator
of the Plan. In any event, no Change of Ownership Transaction involving the Company shall, without
the written consent of a Participant, eliminate or reduce any Benefit of the Participant under the
Plan to which, as of the date of such Change of Ownership Transaction, such Participant would be
entitled under the provisions of Section 5 had he or she ceased serving as a Director immediately
prior to such date.

10.   Miscellaneous

     10.1   Benefits Fully Vested.   All Benefits under the Plan, to the extent accrued, shall be
fully vested at all times hereunder.

9

 

     10.2   No Right to Continue as Director.   Nothing contained in this Plan or in any agreement or
instrument executed pursuant to the Plan shall be construed as conferring upon any Participant the
right to continue serving as a Director.

     10.3   Successors and Assigns.   This Plan shall be binding upon the Company and its successors
and assigns as well as each Participant and his or her representatives, successors, heirs, assigns,
and Beneficiary.

     10.4   Assignment or Alienation.   To the extent permitted by law, benefits of Participants under
this Plan may not be anticipated, assigned (either by law or in equity), transferred, alienated or
subject to attachment, garnishment, levy, execution or other legal or equitable process.

     10.5   Entire Agreement.   The Plan and a Participant’s Deferred Compensation Agreement, and any
subsequently adopted amendment to either of these documents, shall constitute the total agreement
or contract between the Company and such Participant regarding the Plan. No oral statement
regarding the Plan may be relied upon by the Participant. If there are any conflicts between the
terms of the Plan and a Participant’s Deferred Compensation Agreement, the terms of the Plan shall
control.

     10.6   Headings.   The headings herein are for reference only. In the event of a conflict
between a heading and content of a Section of this Plan, the content of the Section shall control.

     10.7   Gender and Number.   Whenever used herein, the masculine shall be interpreted to include
the feminine and neuter, the neuter to include the masculine and feminine, the singular to include
the plural and the plural to include the singular, unless the context requires otherwise.

     10.8   Governing Law.   The place of administration of this Plan shall conclusively be deemed to
be within the State of California, and the Plan shall be governed by and in all respects

     construed in accordance with the substantive laws of the State of California, except where such
laws are superseded by federal laws.

     10.9   Compliance with Section 409A of the Code.   This Plan is intended to comply with the
requirements of Section 409A of the Code and regulations and other guidance thereunder. The
Committee shall interpret the Plan provisions with respect to Post-2004 Deferrals in a manner
consistent with the requirements of Section 409A of the Code and regulations and other guidance
thereunder. To the extent one or more provisions of this Plan do not comply with Section 409A of
the Code, such provision shall be automatically and immediately voided, and shall be amended as
soon as administratively feasible and shall be administered to so comply.

     10.10   Scrivener’s Error.   Notwithstanding any other provision of this Plan to the contrary, if
there is a scrivener’s error in properly transcribing this Plan document, it shall not be a
violation of the Plan terms to operate the Plan in accordance with its proper provisions, rather
than in accordance with the terms of the Plan document, pending correction of the Plan document
through an amendment. In addition, any provisions of the Plan document improperly added as a
result of scrivener’s error shall be considered null and void as of the date such error occurred.

10

 

     10.11   Plan Restatement Effective Date.   This Restatement of the Plan shall be effective with
respect to all Participants, Beneficiaries and any person claiming benefits under the Plan on or
following January 1, 2005, except as otherwise expressly indicated to the contrary.

     In Witness Whereof, the Company has executed this Restatement of the Plan as of this
20th day of December, 2005.

	 	 	 	 	 	 	 
	 	 	IDM Pharma, Inc.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:
	 	/s/ Robert De Vaere
	 	 
	 

	 	 	 	 	 	 
	 

	 	Title:
	 	Chief Financial Officer	 	 
	 

	 	 	 	 	 	 

11

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]